Axsome Therapeutics Inc. logo

Axsome Therapeutics Inc.

AXSM | NASDAQ
Chart Builder DCF Calculator
$132.03
-$12.40 (-8.59%)
Nov 2, 2026, 2:31 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Net Income
-183.17M -287.22M -239.24M -187.13M -130.4M -102.9M
Depreciation & Amortization
9.06M 7.96M 6.83M 4.4M 76K 77.72K
Stock-Based Compensation
93.75M 85.22M 62.62M 37.73M 20.8M 14.76M
Other Working Capital
82.07M 52.2M 34.81M 41.19M 685K -2.15M
Other Non-Cash Items
9.48M 31.73M 53.1M 4.83M 974K 7.95M
Deferred Income Tax
n/a n/a n/a n/a n/a 1.25M
Change in Working Capital
-22.52M 33.9M -28.39M 23.67M 324K 412.04K
Operating Cash Flow
-93.41M -128.41M -145.08M -116.51M -108.23M -78.46M
Capital Expenditures
-480K -270K -582K -702K -308K -45.89K
Cash Acquisitions
n/a n/a n/a -53M n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-480K -270K -582K -53.7M -308K -45.89K
Debt Repayment
-7.75M -990K 85M 45M n/a 28.34M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-17.05M 18.05M -12.74M -4.18M 3.69M -52.76K
Financial Cash Flow
101.47M 57.84M 331.01M 284.58M 11.13M 42.41M
Net Cash Flow
7.58M -70.84M 185.35M 114.37M -97.4M -36.09M
Free Cash Flow
-93.89M -128.68M -145.66M -117.21M -108.53M -78.5M
Adj. Free Cash Flow
-187.64M -213.9M -208.28M -154.94M -129.34M -93.26M
Maintenance CapEx
n/a n/a n/a n/a -76K -45.89K
Growth CapEx
-480K -270K -582K -702K -232K n/a
Owner Earnings
-93.41M -128.41M -145.08M -116.51M -108.3M -78.5M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.